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Fluorescence in situ hybridization (FISH) is a macromolecule recognition technology
based on the complementary nature of DNA or DNA/RNA double strands. Selected
DNA strands incorporated with fluorophore-coupled nucleotides can be used as probes
to hybridize onto the complementary sequences in tested cells and tissues and then
visualized through a fluorescencemicroscope or an imaging system. This technology was
initially developed as a physical mapping tool to delineate genes within chromosomes. Its
high analytical resolution to a single gene level and high sensitivity and specificity enabled
an immediate application for genetic diagnosis of constitutional common aneuploidies,
microdeletion/microduplication syndromes, and subtelomeric rearrangements. FISH
tests using panels of gene-specific probes for somatic recurrent losses, gains, and
translocations have been routinely applied for hematologic and solid tumors and are
one of the fastest-growing areas in cancer diagnosis. FISH has also been used to
detect infectious microbias and parasites like malaria in human blood cells. Recent
advances in FISH technology involve various methods for improving probe labeling
efficiency and the use of super resolution imaging systems for direct visualization of
intra-nuclear chromosomal organization and profiling of RNA transcription in single
cells. Cas9-mediated FISH (CASFISH) allowed in situ labeling of repetitive sequences
and single-copy sequences without the disruption of nuclear genomic organization in
fixed or living cells. Using oligopaint-FISH and super-resolution imaging enabled in situ
visualization of chromosome haplotypes from differentially specified single-nucleotide
polymorphism loci. Single molecule RNA FISH (smRNA-FISH) using combinatorial
labeling or sequential barcoding by multiple round of hybridization were applied to
measure mRNA expression of multiple genes within single cells. Research applications
of these single molecule single cells DNA and RNA FISH techniques have visualized
intra-nuclear genomic structure and sub-cellular transcriptional dynamics of many genes
and revealed their functions in various biological processes.
Keywords: fluorescence in situ hybridization (FISH), genetic diagnosis, aneuploidy, pathogenic copy number
variants (CNV), microdeletion/microduplication syndromes, Cas-9 mediated FISH (CASFISH), oligopaint-FISH,
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INTRODUCTION
Fluorescence in situ hybridization (FISH) uses DNA fragments
incorporated with fluorophore-coupled nucleotides as probes to
examine the presence or absence of complementary sequences
in fixed cells or tissues under a fluorescent microscope.
This hybridization-based macromolecule recognition tool was
very effective in mapping genes and polymorphic loci onto
metaphase chromosomes for constructing a physical map of
the human genome (Langer-Safer et al., 1982; Lichter et al.,
1993). FISH technology offers three major advantages including
high sensitivity and specificity in recognizing targeted DNA
or RNA sequences, direct application to both metaphase
chromosomes and interphase nuclei, and visualization of
hybridization signals at the single-cell level. These advantages
increased the analytic resolution from Giemsa bands to the
gene level and enabled rapid detection of numerical and
structural chromosomal abnormalities (Klinger et al., 1992;
Ried et al., 1992). Clinical application of FISH technology
had upgraded classical cytogenetics to molecular cytogenetics.
With the improvement in probe labeling efficiency and the
introduction of a super resolution imaging system, FISH has
been renovated for research analysis of nuclear structures and
gene functions. This review presents the recent progress in
FISH technology and summarizes its diagnostic and research
applications.
CELL BASED GENETIC DIAGNOSIS BY
FISH
Analytical and Clinical Validities and
Practice Guidelines
Most DNA fragments used as probes are extracted from bacterial
artificial clones (BACs) which contain cloned human genomic
DNA sequences in the size of 100–200 Kilobases (Kb). These
DNA fragments could be directly labeled by nick translation
to incorporate nucleotides coupled with different fluorophores
such as coumarins, fluoresceins, rhodamine, and cyanines (Cy3,
Cy5, and Cy7) (Morrison et al., 2003). According to the targeted
regions and labeling design, FISH probes can be divided into
locus-specific probes targeted to specific regions or genes and
regional painting probes for specific chromosomal bands, an
entire chromosome or whole genome. Commonly used locus-
specific probes include alpha repetitive sequences for centromeric
regions and single copy sequences for subtelomeric and gene
regions. Multi-color locus-specific probes allow simultaneously
detection of numerical abnormalities of two to three regions
in one FISH assay. For structural rearrangements, locus-
specific probes with different fluorophores for two genes
or for the 5′ and 3′ regions of a gene have been used
to detect “double-fusion” signals resulting from a reciprocal
translocation or “break apart” signals from a gene rearrangement,
respectively. Painting probes have been used mostly in a research
setting to dissect chromosome domains within a nucleus or
structural rearrangements in metaphase chromosomes. Figure 1
shows representative FISH applications of locus-specific and
chromosome painting probes in the detection of numerical and
structural chromosomal abnormalities.
Earlier studies had evaluated signal-to-noise ratios, spatial
resolution of the fluorescent signals, and hybridization/detection
efficiencies of FISH tests on lymphocytes and aminocytes
(Klinger et al., 1992; Ried et al., 1992). These studies led to
the commercialization of FISH probes with optimized probe
selection and standardized labeling, and the clinical utility of
FISH testing in large case series (Ward et al., 1993). To ensure
safe and effective diagnostic application, a clinical cytogenetics
laboratory needs to establish the analytical and clinical validities
for every FISH assay. The analytical validity of a FISH assay
is evaluated by its targeted accuracy, sensitivity, specificity, and
normal reference ranges following a standardized laboratory
procedure (Wolff et al., 2007; Ciolino et al., 2009). FISH testing
could be used as an adjunctive assay or a stand-alone diagnostic
assay for constitutional and somatic abnormalities. The clinical
validity for its intended use should be evaluated by calculating
the sensitivity from patients with targeted abnormalities and the
specificity from normal controls. Other analytical and clinical
considerations include possible false positive or negative results,
continuous monitoring of signal variations, periodical evaluation
and batch-to-batch comparisons of probe performances (Test
and Technology Transfer Committee, 2000).
FISH technology enabled the detection of an increased
spectrum of genetic disorders from chromosomal abnormalities
to submicroscopic copy number variants (CNVs) and extended
the cell-based analysis from metaphases to interphases (Xu
and Li, 2013). The analytical resolution of FISH is in the
range of 100–200 Kb as determined by the probe size, which
is 50-fold higher than the 5–10 megabase (Mb) Giesma
banding of a high resolution karyotyping. Locus-specific probes
detected submicroscopic CNV and led to the identification of
a group of genomic disorders (also termed contiguous gene
syndromes or microdeletion syndromes), such as DiGeorge
syndrome (OMIM#188400) by a deletion at 22q11.2, Prader-
Willi syndrome (OMIM#176270) and Angelman syndrome
(OMIM#105830) by a deletion at 15q11.2. FISH can be
performed directly on interphase nuclei, which eliminated
the time consuming cell culture procedure and extended its
diagnostic application toward rapid screening of chromosomal
and genomic abnormalities. In the following sections, the
diagnostic applications of FISH technology are focused on
three main areas: prenatal screening and postnatal diagnosis of
constitutional chromosomal abnormalities and submicroscopic
pathogenic CNVs, identification and monitoring of acquired
chromosomal abnormalities in hematopoietic and solid tumors,
and the detection of infectious diseases caused by microbials and
parasites.
Detection of Constitutional Chromosomal
Abnormalities and Pathogenic CNVs
A Multiplex FISH panel with differentially labeled probes has
been developed for prenatal screening of common aneuploidies
involving gains or losses of chromosomes X, Y, 13, 18, and
21 (Ried et al., 1992; Ward et al., 1993). Pregnant women
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FIGURE 1 | Adjunctive and diagnostic assays of FISH in clinical cytogenetics. (A) The detection of di-centric, tri-centric, and tetra-centric ring chromosome 18
using a centromeric probe D18Z2 for chromosome 18. Left panel shows normal chromosome 18, dicentric ring 18 in top, and tetracentric ring 18 in bottom, right
panel shows dicentric ring 18 and tricentric/tetracentric ring 18 in insets by FISH. (B) The detection of a derivative chromosome 16 from a 2q32/16p13.3 translocation
by whole chromosome painting probes for chromosomes 2 (WCP2) and 16 (WCP16). (C) The detection of ABL1/BCR gene fusions in interphase and metaphase cells
by dual color double fusion probes (thin arrows point to the normal signal and thick arrows point to the abnormal fusion signals). (D) Diagnostic use of ETV6 and
RUNX1 probes for the detection of two fusion signals for a cryptic t(12;21)(p13;q22), loss of an ETV6 signal and gain of three extra RUNX1 signals (thin arrows point to
the fusion signals and thick arrows to extra RUNX1 signals). All images are from Yale clinical cytogenetics laboratory.
with a single indication or combined indications of advanced
maternal age, abnormal ultrasound findings, or abnormal
maternal serum screening have an increased risk of 4–30% for
carrying numerical and structural chromosomal abnormalities;
among these abnormalities, 84% were numerical abnormalities
mostly detectable by the multiplex FISH panel, and 16% were
structural abnormalities required further microarray analysis (Li
et al., 2011). For prenatal cases with cardiac anomalies detected
by prenatal ultrasound examination, DiGeorge syndrome was
detected by FISH. Recently, the application of non-invasive
prenatal testing by massive parallel sequencing on maternal cell-
free fetal DNA significantly improved the accuracy of aneuploidy
screening, which resulted in a 57% decline in invasive prenatal
procedures and an increase of diagnostic yield of chromosomal
abnormalities (Xu Z. Y. et al., 2013; Meng et al., 2015). Despite
these technology advances in prenatal diagnosis, the multiplex
FISH panel is still used as an adjunctive assay for rapid detection
of common aneuploidies. It should be noted that false positive
or negative results as well as maternal cell contamination have
been noted in prenatal FISH analysis. Therefore, an irreversible
therapeutic action should not be initiated on the basis of FISH
results alone. The current guideline recommended that clinical
decisions should bemade based on two of three pieces of available
information: FISH results, conventional cytogenetic analysis and
clinical information (Test and Technology Transfer Committee,
2000). Furthermore, aneuploidies and polyploidies have been
detected in about 50% of first trimester spontaneous abortions
by chromosome analysis and in 35% of products of conception
culture failure cases by microarray analysis; it is recognized that
an extended FISH panel for chromosomes X/Y/18, 13/21, and
15/16/22 will detect all polyploidies, 84% of aneuploidies, and
69% of multiple aneuploidies causing miscarriages (Zhou et al.,
2016).
Developmental delay, intellectual disabilities, and multiple
congenital anomalies are present in 1–5% of newborns, and
chromosome microarray analysis as the first tier genetic testing
has detected a spectrum of cytogenomic abnormalities in
10∼20% of these patients (Miller et al., 2010; Li et al., 2015).
Analysis of abnormal findings from consecutive pediatric cases
observed genomic disorders (microdeletion/microduplication
syndromes), subtelomeric rearrangements, interstitial
imbalances, chromosomal structural rearrangements, and
aneuploidies in about 37, 26, 19, 10, and 8% of these cases,
respectively (Xu et al., 2014). Cell-based FISH testing has
been a cost-effective adjunctive assay to confirm microarray
detected genomic disorders and then to detect carrier statues
in a follow-up parental study. Microdeletions can be detected
as a loss of one signal in metaphases and interphases, while
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microduplications can be detected as “twin-spot” like two signals
in the interphase nuclei. For subtelomeric rearrangements,
a complete set of subtelomeric FISH probes for all human
chromosomes was developed (Ning et al., 1996) and have been
used routinely as an adjunctive assay in visualizing cryptic and
complex subtelomeric rearrangements (Li et al., 2006; Rossi
et al., 2009). For many newly defined loci of genomic disorders
and interstitial imbalances, there are no commercially available
FISH probes. Therefore, “home-brew” targeted BAC clone FISH
probes were used for these unique cases (Li et al., 2006; Khattab
et al., 2011).
Structural rearrangements like ring chromosomes and small
supernumerary marker chromosomes (sSMC) present not only
segmental gains or losses but also a mosaic pattern due to
their dynamic behavior in mitosis. As shown in Figure 1A,
centromeric FISH probes are routinely used to track the changes
from dicentric, tricentric, and tetracentric ring chromosomes to
loss of the ring through mitosis. Subtelomeric and interstitial
FISH probes have been used to define the intactness of the ring
chromosome and the level of mosaicism (Zhang et al., 2004; Xu F.
et al., 2013). A cytogenomic approach combining chromosome,
FISH, and microarray analyses has been recommended for
characterizing the genomic structure, mitotic instability, and
mechanisms of ring formation for cases with a ring chromosome
(Zhang et al., 2012). sSMC are extra centric chromosome
fragments usually in the forms of an inverted duplication or
a small ring chromosome and present in 0.043% of newborn
children. Several sSMC have syndromic phenotypes such as inv
dup(22q11.2) for cat-eye syndrome (OMIM∗607576) and i(12p)
for Pallister Killian syndrome (OMIM#601803), and others
like inv dup(15q) and i(18p) can have variable phenotypes
(Liehr et al., 2004, 2006). About 30% of sSMC are derived
from chromosome 15; the D15S10 or SNRPN probes are
routinely used to assess inv dup(15q) (Wang et al., 2015). The
euchromatic material in sSMC can be detected by a microarray
analysis. A set of pericentric core probes for each arm of
human chromosomes has been validated for characterizing
unambiguously the chromosomal origin of sSMC and the level
of mosaicism (Castronovo et al., 2013).
Identification and Monitoring of Acquired
Chromosomal Abnormalities
The discovery of Philadelphia chromosome in chronic
myeloid leukemia (CML) followed by the characterization
of t(9;22)(q34;q11) with underlying ABL1/BCR gene fusions
supported the causative role of chromosomal abnormalities in
carcinogenesis and set the foundation for cancer cytogenetics
(Mitelman et al., 2007). Cancer is considered a genetic disease
at the cellular level resulting from either a progressive process
or a one-off catastrophic event (Stephens et al., 2011; Li
and Cui, 2016). The two main pathogenetic pathways for
hallmarks of cancer development are the inactivation of tumor
suppressor genes by deletions, mutations, miRNA upregulation,
or epigenetic mechanisms, and the activation or deregulation of
oncogenes as a consequence of point mutations, amplification
or balanced cytogenetic abnormalities (Vogelstein and Kinzler,
2004; Hanahan and Weinberg, 2011). Recurrent chromosomal
abnormalities including translocations, deletions, duplications,
and gene amplifications associated with distinct tumor entities
have been characterized; specifically designed FISH panels have
been widely used in the diagnosis and monitoring of acquired
chromosomal abnormalities in hematologic and solid tumors
(Hu et al., 2014; Liehr et al., 2015; Mikhail et al., 2016).
Current guidelines recommend an integrated approach for
cancer cytogenetic diagnosis (Wolff et al., 2007). In general, both
conventional karyotyping and FISH testing are used for initial
diagnosis and follow up monitoring of clonal abnormalities. For
hematopoietic and lymphoid tumors, the most commonly used
FISH probes and disease-specific panels in a clinical cytogenetics
laboratory are listed in Table 1. Results from a FISH panel
offer a quick evaluation of targeted abnormal patterns and
their percentage within the bone marrow cells or leukocytes.
Chromosome analysis will then reveal the clonal abnormalities
and clonal evolution. For leukemias requiring urgent treatment,
such as acute promyelocytic leukemia (APL) caused by the
t(15;17)(q24;q21) with underlying PML/RARa fusions, rapid
FISH result is mandated for the administration of all-trans
retinoic acid (ATRA). Targeted therapy against the ABL1/BCR
fusion protein by small molecule tyrosine inhibitors like imatinib
mesylate (Gleevec), dasatinib (Sprycel), and nilotinib (Tasigna)
has increased the 10-year overall survival from 20 to 80–90%
(Li et al., 2013). For many cryptic rearrangements undetectable
by routine chromosome analysis, such as t(12;21)(p13;q22)
with ETV6/RUNX1 gene fusions, t(4;14)(p16.3;q32) with
FGFR3/IGH gene fusions, deletions of 12p13 (ETV6), 13q14
(RB1), and 17p13 (TP53), FISH tests are considered a stand-
alone diagnostic assay. Adjunctive use of FISH probes to further
define ambiguous or hidden chromosomal abnormalities is
required for many cases (Kamath et al., 2008; Massaro et al.,
2011). Additionally, FISH is a sensitive and timely method
to monitor residual diseases with known clonal abnormality
and bone marrow transplantation by sex-mismatch donor
at cellular level. Considering some hematologic tumors may
be morphologically similar and the abnormalities may not
be detected by low-resolution karyotyping and/or in low
percentage of leukemic cells, FISH could be important for
differential diagnosis between these diseases. For example,
cyclin D1 (CCND1) translocation can be detected by FISH
as a characteristic abnormality in mantle cell lymphoma,
which provides differential diagnosis for morphologically
similar chronic lymphoid leukemia (CLL). Furthermore, FISH
for nuclear DNA can be combined with immunostaining
of cytoplasmic markers for simultaneous identification of
chromosomal abnormalities and cell types. For example, IGH
translocation is present in multiple myeloma and monoclonal
gammopathy of undetermined significance (MM/MGUS)
with high frequency, which is usually detected in plasma
cells. In a two-step assay with first the hybridization of IGH
probe and then immune-staining by fluoresceinisothiocyanate
(FITC)-conjugated antibodies against κ- or λ-light chain, the
FITC-stained cytoplasm and IGH break apart signals within
the nuclei were visualized in plasma cells simultaneously. This
modified immuno-FISH was expected to improve the diagnostic
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TABLE 1 | List of FISH panels and probes for hematopoietic and lymphoid tumors.
Gene (G-band) Probe Design Myeloid leukemia Lymphocytic leukemia Lymphoma MM/MGUS MPD
CML MDS AML CLL B-ALL T-ALL
CKS1B (1q21), CDKN2C
(1p32)
DCE 1p/1q+
PBX1 (1q23.3), TCF3
(19p13.3)
DCDF t(1;19) t(1;19)
ALK (2p23) DCBAP ALK
MECOM (3q26) DCBAP inv(3)
BCL6 (3q27) DCBAP BCL6
D4Z1 (4cen), D10Z1
(10cen), D17Z1 (17cen)
TCE +4/10/17
PDGFRA (4q12) DCBAP PDGFRA
FGFR3 (4p16.3), IGH
(14q32)
DCDF t(4;14)
TAS2R1 (5p15.31), EGR1
(5q31)
DCE 5q−/−5
PDGFRB (5q33) DCBAP PDGFRB PDGFRB
MYB (6q23), D6Z1 (6cen) DCE 6q−
RELN (7q22), TES (7q31) DCE 7q−/−7
TCRB (7q34) DCBAP TCRB
FGFR1 (8p11) DCBAP FGFR1
RUNX1T1 (8q21), RUNX1
(21q22)
DCDF t(8;21)
cMYC (8q24) DCBAP cMYC
cMYC (8q24), D20S108
(20q12)
DCE +8/20q−
PAX5 (9p13.2) DCBAP PAX5
CDKN2A (9p21), D9Z3
(9cen)
DCE 9p− 9p−
ABL (9q34), BCR (22q11) DCDF t(9;22) t(9;22) t(9;22)
CCND1 (11q13), IGH
(14q32)
DCDF t(11;14) t(11;14)
ATM (11q22), TP53
(17p13)
DCE 11q−/17p−
KMT2A (11q23) DCBAP KMT2A KMT2A KMT2A
ETV6 (12p13), RUNX1
(21q22)
DCDF t(12;21)
DLEU1 (13q14), D13S25
(13q34)
DCE 13q−
DLEU1 (13q14), D13S25
(13q34), D12Z3 (12cen)
TCE 13q−/+12
TCRA/D (14q11) DCE TCRA
IGH (14q32) DCBAP IGH IGH IGH
IGH (14q32), BCL2
(18q21)
DCDF t(14;18)
SNRPN (15q11.2), TP53
(17p13)
DCE +15/17p−
PML (15q24), RARA
(17q21)
DCDF t(15;17)
MYH11 (16p13), CBFB
(16q22)
DCDF inv(16)
MALT1 (18q21) DCBAP MALT1
CRLF2 (Xp22.33) DCBAP CLFR2
DCE,dual-color enumerate; TCE, tri-color enumerate; DCBAP, dual-color break apart; DCDF, dual-color double fusion; CML, Chronic myeloid leukemia; MDS, Myelodysplastic
syndrome; AML, Acute myeloid leukemia; CLL, Chronic lymphocytic leukemia; B-ALL, B-cell acute lymphocytic leukemia; T-ALL, T-cell acute lymphocytic leukemia; MM/MGUS, Multiple
myeloma/Monoclonal mopathy of undetermined significance; MPD, Myeloproliferative disorder. Shaded for recurrent abnormalities detected by a primary FISH panel, unshaded for
secondary FISH probes for specific abnormalities. For references see (Hu et al., 2014; Liehr et al., 2015), and (Mikhail et al., 2016).
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accuracy but the low sensitivity limited its application only in
follow-up study (Boersma-Vreugdenhil et al., 2003).
FISH tests are widely used in various types of solid
tumors. For example, FISH can define gene rearrangements
in congenital fibrosarcoma with a novel complex translocation
(Marino-Enriquez et al., 2008) and validate subclone markers
in heterogeneous melanoma biopsies (Parisi et al., 2011).
FISH results can be used to guide cancer treatment. For
example, Herceptin-targeted therapy is effectively against HER2
over-expressed breast cancer. For routine clinical specimen,
immunohistochemistry, real-time polymerase chain reaction,
and FISH were used to assess the HER2 protein level, RNA
expression, and DNA copy numbers, respectively. Among
these methods, FISH offered a cell-based evaluation for the
ratio of HER2 gene copy number to the number of copies
of chromosome 17 (HER2/CEP17 ratio). The FISH scoring
criteria for HER2/CEP17 ratio and the interpretive guidelines
were reported (Hicks et al., 2005). Many targeted therapies
for recurrent translocations in various types of solid tumors
have been either approved by FDA or are under clinical trials.
For example, lapatinib, sorafenib, sunitinib, termsirolimus, and
pazopanib have been used for papillary renal cell carcinoma with
translocations involving the TFE3 gene at Xp11.2; cixutumumab
and mithramycin are in phase II clinical trial for Ewing sarcoma
with translocation involving the EWSR1 gene at 22q12 (Li
et al., 2013). FISH assays using probes for specific recurrent
translocations from different solid tumors could guide effective
targeted therapy. FISH tests were also used to evaluate sperm
aneuploidy frequencies before and after chemotherapy in patients
with testicular cancer and Hodgkin’s lymphoma; significantly
increased frequencies of aneuploidies for a duration up to 24
months were noted (De Mas et al., 2001; Tempest et al., 2008).
It was recommended that genetic counseling about potentially
increased reproduction risk from chemotherapy should be
offered to cancer patients.
Detection of Infectious Diseases by FISH
The majority of FISH probes target to specific chromosomal
and genomic abnormalities in the human genome. Rapid
phylogenetic identification of single microbial cells was achieved
using fluorescently labeled oligonucleotides complementary to
16S ribosomal RNA (rRNA) (DeLong et al., 1989). Some
segments in the 16S rRNA are invariant in all organisms but
phylogenetic group-specific 16S rRNA in different groups of
organism can be used as oligonucleotide FISH probes (length 17–
34 nucleotides) to identify infectious agents in clinical samples.
For example, FISH probes complementary to specific sequence
of 16s rRNA can detect malaria infection in blood samples. The
Plasmodium Genus (P-Genus) FISH assay has a Plasmodium
genus specific probes that detect all five species of Plasmodium
known to cause the disease in humans. The sensitivity of this
FISH assay is better than the Giemsa staining method. A LED
light source may be an available device to read FISH result,
which can extend the clinical application of FISH especially in the
resource-limited areas. Since rRNA has a short life and is present
in a live organism with plenty of copies, FISH should be done in
the live pathogens (Shah et al., 2015).
SINGLE-CELL DNA STRUCTURAL AND
RNA TRANSCRIPTIONAL ANALYSES
FISH assays using locus-specific and regional painting probes
are still a powerful tool in visualizing simple and complex
chromosomal and genomic rearrangements. Fiber-FISH by
locus-specific BAC clone probes within a 900 Kb 17q12
inversion hybridizing onto stretched DNA fibers correlated
the inversion orientations with associated haplotypes,
which allowed the evaluation of inversion frequencies
among human populations globally (Donnelly et al., 2010).
Pericentriomeric heterochromatin probes were used in a three
dimensional FISH (3D-FISH) to study intra-nuclear centromeric
positions in cultured cells from patients with ICF syndrome
(immunodeficiency, centromeric region instability, facial
anomalies) and Robert syndrome (cohesion defect by mutations
in the ESCO2 gene) (Dupont et al., 2012, 2014). Multi-color FISH
(M-FISH) by painting probes specific for a human chromosome
and multi-color banding FISH (M-BAND) by painting probes
specific for every band in a chromosome were used to visualize
complex chromosomal rearrangements from chromothripsis
in two patients with acute myeloid leukemia (Mackinnon and
Campbell, 2013). Chromothripsis are seen as regional clustering
of breakpoints and regularity of oscillating copy-number
states by microarray analysis and as heterogeneous staining
regions, marker or ring chromosomes, and other undefinable
rearrangements by chromosome analysis (Stephens et al., 2011).
Selected FISH probes targeting to the oscillating copy-number
gains and losses could be used to monitor the abnormal clones
with chromothripsis.
FISH technology has made significant progress with the
innovation of novel labeling methods and the introduction of
super resolution imaging systems for fine mapping of intra-
nuclear genomic structures and for single cells single molecule
profiling of cytoplasmic RNA transcription. Recently, a novel
FISH method using nuclease-deficient clustered regularly
interspaced short palindromic repeats (CRISPR)/CRISPR-
associated caspase 9 (dCas9) system was developed. The initial
design used enhanced green fluorescent protein (EGFP) tagged
dCas9 and small guide RNA (sgRNA) targeting to repetitive
telomere sequences or sgRNAs tiling along a non-repetitive
genomic sequences at the MUC4 locus. This method enabled
the visualization of intra-nuclear locations and dynamics of
telomeres and MUC4 loci during mitosis in living human
cells (Chen et al., 2013). Further modification by using both
fluorophore-coupled sgRNA and fluorophore-coupled dCas9
was termed Cas9-mediated FISH (CASFISH); rapid and
robust labeling of repetitive DNA elements in preicentromere,
centromere, G-rich telomere, and MUC4 gene by CASFISH was
demonstrated (Figure 2A; Deng et al., 2015). This CASFISH
did not require the denature treatment for targeted DNA and
therefore preserved the nature spatiotemporal organization
of the nucleus. The CASFISH process is remarkably rapid
(within 1 h) and can be used directly on fixed tissues or
living cells. However, using tiling sgRNAs for single-copy
gene regions could have low labeling efficiency and higher
background. Further optimization of this CASFISH technology
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FIGURE 2 | Single molecule FISH techniques for research application in single cells. Schematic drawings of single molecule FISH methods: (A) Cas-9
mediated FISH (CASFISH) using fluorophore-coupled sgRNAs and dCAS9. (B) Oligopaint-FISH using fluorophore-coupled primary oligonucleotides for targeted SNP
loci and fluorophore-coupled second oligonucleotide to enhance labeling efficiency shows differential labeling of paternal (pat) and maternal (mat) chromosomes. (C)
single molecule RNA FISH by rolling cycling amplification (RCA) using padlock probes targeting to reverse transcripted cDNA with different alleles followed by ligation,
cycling amplification and specific fluorophore-couple probe hybridization and visualization. (D) Sequential barcoding of multiplex different mRNAs by repeat rounds of
hybridization, imaging, and stripping. Star, diamond, and triangle are symbols for different fluorophores.
is needed before its application for basic research and genetic
diagnosis.
A synthesized primary single-strand oligonucleotide
library targeting to a single copy region of the genome
along with fluorophore-coupled second oligonucleotides
complementary to a portion of the primary oligonucleotides
were developed for so-called oligopaint FISH (Beliveau et al.,
2015). Co-hybridization of a set of hundreds to thousands of
primary fluorophore-coupled oligopaint probes (30–42 bases
in length for targeted genome region and hinged 14–32 bases
for second oligonucleotides) with fluorophore-coupled second
oligonucleotide (14–32 bases) can visualize a 52 Kb–3Mb regions
in nuclei with a 96–100% hybridization efficiency. Oligopaint
FISH probes designed with one fluorophore for specified single
nucleotide polymorphisms (SNPs) in a targeted region from one
chromosome and another fluorophore for these SNPs in the
homology chromosome enabled differential labeling of the two
homologous chromosomes. Stochastic optical reconstruction
microscope (STORM) was used for single-molecule super-
resolution imaging. Therefore, with prior information of the
specific SNP alleles from the two homologous chromosomes,
oligopaint FISH showed in situ haplotyping for paternal and
maternal chromosomes (Figure 2B). The oligopaint probes are
chosen bioinformatically to avoid repetitive DNA sequences and
they can be selected to target any organisms whose genomes have
been sequenced. With further improvement on signal pattern
recognition from the SNP loci, oligopaint FISH should enable
direct analysis of fine-scale chromatin structure, differential
visualization of homologous chromosomes, and allele-specific
studies of gene expression.
RNA FISH is a cell-based technique for detecting mRNA
transcripts. With the advance of various methods for signal
amplification and super-resolution imaging, single molecule
RNA FISH (smRNA-FISH) techniques have been developed.
Several approaches, including branched DNA probes, tyramide
signal amplification, quantum dots, and padlock-rolling circle
amplification (RCA), have been used for signal enhancement
(Kwon, 2013). RCA is the only method capable of distinguishing
single nucleotide allelic changes in transcripts. Briefly, reverse
transcription was performed in situ on cells and tissue sections to
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generate complementary DNA (cDNA), themRNAwas degraded
by ribonuclease H, and then padlock probes were hybridized to
targeted cDNA with 5′ and 3′ arms circularized by a T4 DNA
ligase. The circularized padlock probes served as a template for
RCA by 829 DNA polymerase, and then fluorophore-couple
oligonucleotide probes specific for each padlock probe could be
hybridized and visualized (Figure 2C; Larsson et al., 2010). To
increase the capacity for multiplex detection of different mRNA
molecules in single cells, combinatorial labeling, and optical
super-resolution microscope were used to measure mRNA levels
of 32 genes simultaneously in single Saccharomyces cerevisiae
cells (Lubeck and Cai, 2012). Further modification introduced
a sequential barcoding scheme for multiplex different mRNA
quantitation (Lubeck et al., 2014). In this scheme, the mRNAs
in cells were barcoded by sequential rounds of hybridization,
imaging and probe stripping (Figure 2D). Theoretically, the
multiplexing capacity scaled up quickly as the number of
fluorophores and rounds of hybridization increased. In practice,
the available fluorophores were limited and each round of
hybridization introduced loss of the RNA integrity in the tested
cells.
Various smRNA-FISH methods have been used in imaging
cell-type specific RNA profiles and sub-cellular localization
patterns of mRNAs in in vitro cellular systems (Ronander
et al., 2012; Lalmansingh et al., 2013; Shaffer et al., 2013;
Sinnamon and Czaplinski, 2014) and model animals such as
Drosophila (Zimmerman et al., 2013), Caenorhabditis elegans
(Bolková and Lanctôt, 2015), and Zebrafish (Hauptmann et al.,
2016). Additionally, smRNA FISH has been used to study
the subcellular localization and cell-to-cell variability of long
non-coding RNAs (lncRNA); systematically quantification and
categorization based on the subcellular localization patterns were
achieved for a representative set of 61 lncRNAs in three different
cell types (Cabili et al., 2015). Knowledge of lncRNA subcellular
localization patterns is essential to understand its biological
processes. An interesting application of smRNA FISH is the
study on nuclear RNA foci in genetic diseases resulting from the
expansion of tri-, tetra-, penta-, and hexa-nucleotide repeats; a
detailed protocol was reported for detecting mRNAs containing
expanded CAG and CUG repeats in fibroblasts, lymphoblasts,
and induced pluripotent stem cells (Urbanek and Krzyzosiak,
2016).
Simultaneous detection of mRNA and protein quantity
and their subcellular distribution in single cells by combining
a RNase-free modification of the immunofluorescence (IF)
technique and the smRNA FISH method observed direct
interaction of RNase MCPIP1 with IL-6 mRNA (Kochan
et al., 2015). Real-time live imaging using laser-scanning
confocal microscope with photon-counting detectors for
quantitative studies of transcription in culture cells and model
animals have been achieved by smRNA-FISH and GFP-tagged
reporter gene for RNA polymerase (Gregor et al., 2014).
Using Drosophila embryo as a testing system, smRNA-FISH
observed stochastic transcriptional activity of four critical
patterning genes and co-packaging of transcripts as multi-
copy heterogeneous granules to selected subcellular domains
(Little et al., 2013, 2015). These results indicated that there are TA
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conserved mechanisms of precision mRNA transcription and
localization for spatiotemporal control of protein synthesis in
regulating cellular and embryo development.
CONCLUSIONS AND FUTURE
DIRECTIONS
In summary, FISH has a wide spectrum of diagnostic and
research applications as shown in Table 2. FISH has the
advantage that it can be used in metaphase chromosomes and
interphase nuclei, and thus offers a cell-based genetic diagnosis
in complementary to DNA-based molecular testing (Xu and Li,
2013). FISH has been used as adjunctive and diagnostic assays
for both constitutional and somatic cytogenomic abnormalities.
FISH analysis of uncultured interphase cells from amniotic fluid
or chorionic villus samples is a standard procedure for rapid
prenatal testing of common aneuploidy and genomic disorders,
which alleviates much anxiety for patients and physicians. The
use of interphase FISH has been particularly fruitful for cancer
cytogenetics, where the detection of recurrent chromosomal
abnormalities and clonal evolution is crucial for classifying
different types of tumors, selecting treatment protocols, and
monitoring outcomes. Even with the introduction of genomic
technologies like microarray analysis and exome sequencing,
FISH analysis will still be an integral part of genetic diagnosis
(Parisi et al., 2012; Wei et al., 2013; Martin and Warburton,
2015). Microfluidic devices for miniaturized and automatic FISH
applications are currently under development (Vedarethinam
et al., 2010; Kwasny et al., 2012; Kao et al., 2015). The validation of
these devices in the near future and the available of more disease-
specific probes will further enhance and expand the diagnostic
FISH application.
Novel FISH techniques and super-resolution imaging systems
have been introduced to study the spatiotemporal changes
of intra-nuclear genomic organization and cytoplasmic RNA
profiling. These FISH techniques such as CASFISH, oligopaint-
FISH, and smRNA-FISH have been developed mainly for genetic
research applications. A current trend in FISH is toward
simultaneous single-cell measurement of DNA, RNA, cell surface
proteins, and intracellular proteins (Lai et al., 2016; Soh et al.,
2016). The translation of these single molecule single cells
FISH techniques into cell-based genetic diagnosis is expected to
improve the analytical resolution and capacity for a spectrum of
genetic defects from chromosomal and genomic abnormalities to
epigenetic aberrations.
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